Heparin-associated antiplatelet antibodies increase morbidity and mortality in hemodialysis patients

Surgery

Volumn 136, Issue 4, 2004, Pages 848-853

  Mureebe, Leila ^b   Coats, Richard D ^a   Silliman, W Ray ^a   Shuster, Thomas A ^a   Nichols, W Kirt ^a   Silver, Donald ^a  

^a UNIVERSITY OF MISSOURI   (United States)

^b New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; THROMBOCYTE ANTIBODY;

ADULT; AGED; ANTIBODY DETECTION; ANTICOAGULATION; ARTICLE; BLEEDING; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOEMBOLISM;

ADULT; AGED; ANTICOAGULANTS; AUTOANTIBODIES; BLOOD PLATELETS; COHORT STUDIES; FEMALE; HEPARIN; HUMANS; MALE; MIDDLE AGED; MORBIDITY; PREVALENCE; RENAL DIALYSIS; RETROSPECTIVE STUDIES; THROMBOCYTOPENIA;

EID: 4744340571     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2004.07.004     Document Type: Article

References (27)

1. J.G. Calaitges, T.K. Liem, D. Spadone, W.K. Nichols, and D. Silver The role of heparin-associated antiplatelet antibodies in the outcome of arterial reconstruction J Vasc Surg 29 1999 779 785 discussion 785-6
2. T.A. Shuster, W.R. Sillman, R.D. Coats, L. Mureebe, and D. Silver Heparin-induced thrombocytopenia: twenty-nine years later J Vasc Surg 38 2003 1316 1322
3. L. Mureebe, and D. Silver Heparin-induced thrombocytopenia: pathophysiology and management Vasc Endovascular Surg 36 2002 163 170
4. J.C. Stiekema Heparin and its biocompatibility Clin Nephrol 26 Suppl 1 1986 S3 S8
5. D. Kapsch, and D. Silver Heparin-induced thrombocytopenia with thrombosis and hemorrhage Arch Surg 116 1981 1423 1427
6. A. Copley, and T. Robb The effect of heparin in vivo on the platelet counts in mice and dogs Am J Clin Pathol 12 1942 563 570
7. R. Weisman, and R. Tobin Arterial embolism occurring during systemic heparin therapy Arch Surg 76 1958 219 227
8. B. Roberts, F. Rosato, and E. Rosato Heparin - a cause of arterial emboli? Surgery 55 1964 803 808
9. G.R. Rhodes, R.H. Dixon, and D. Silver Heparin induced thrombocytopenia with thrombotic and hemorrhagic manifestations Surg Gyn Obst 136 1973 409 416
10. J.I. Almeida, R. Coats, T.K. Liem, and D. Silver Reduced morbidity and mortality rates of the heparin-induced thrombocytopenia syndrome J Vasc Surg 27 1998 309 314 discussion 315-6
11. T. Sitter, M. Spannagl, B. Banas, and H. Schiffl Prevalence of heparin-induced PF4-heparin antibodies in hemodialysis patients Nephron 79 1998 245 246
12. S. Yamamoto, M. Koide, M. Matsuo, S. Suzuki, M. Ohtaka, and S. Saika Heparin-induced thrombocytopenia in hemodialysis patients Am J Kidney Dis 28 1996 82 85
13. S.I. O'Shea, J.J. Sands, S.A. Nudo, and T.L. Ortel Frequency of anti-heparin-platelet factor 4 antibodies in hemodialysis patients and correlation with recurrent vascular access thrombosis Am J Hematol 69 2002 72 73
14. A. Greinacher, S. Zinn, Wizemann, and U.W. Birk Heparin-induced antibodies as a risk factor for thromboembolism and haemorrhage in patients undergoing chronic haemodialysis Lancet 348 1996 764
15. G. Luzzatto, M. Bertoli, G. Cella, F. Fabris, B. Zaia, and A. Girolami Platelet count, anti-heparin/platelet factor 4 antibodies and tissue factor pathway inhibitor plasma antigen level in chronic dialysis Thromb Res 89 1998 115 122
16. K.F. Izban, H.W. Lietz, D.A. Hoppensteadt, W.P. Jeske, J. Fareed, and M. Bakhos Comparison of two PF4/heparin ELISA assays for the laboratory diagnosis of heparin-induced thrombocytopenia [see comment] Semin Thromb Hemost 25 Suppl 1 1999 51 56
17. M. Noris, and G. Remuzzi Uremic bleeding: closing the circle after 30 years of controversies? Blood 94 1999 2569 2574
18. G. Remuzzi, A. Schieppati, and G. Mecca Abnormal platelet function in haemodialysed patients: current concepts Int J Artif Organs 2 1979 109 112
19. S. Meyerson, C. Skelly, M. Curi, T. Desai, D. Katz, and H. Bassiouny Long-term results justify autogenous infrainguinal bypass grafting in patients with end-stage renal disease J Vasc Surg 34 2001 27 33
20. D.J. Leehey, R.J. Kanak, H.L. Messmore, Z.M. Nawab, S. Popli, and T.S. Ing Heparin-associated thrombocytopenia in maintenance hemodialysis patients Int J Artif Organs 10 1987 390 392
21. J. Mudaliar, T.K. Liem, W.K. Nichols, D. Spadone, and D. Silver Lepirudin is a safe and effective anticoagulant for patients with heparin-associated antiplatelet antibodies J Vasc Surg 34 2001 17 20
22. W.E. Dager, and R.H. White Use of lepirudin in patients with heparin-induced thrombocytopenia and renal failure requiring hemodialysis Annals of Pharmacotherapy 35 2001 885 890
23. G. Nowak, E. Bucha, I. Brauns, and R. Czerwinski Anticoagulation with r-hirudin in regular haemodialysis with heparin-induced thrombocytopenia (HIT II). The first long-term application of r-hirudin in a haemodialysis patient [comment] Wien Klin Wochenschr 109 1997 354 358
24. S. Steuer, C. Boogen, J. Plum, C. Deppe, H. Reinauer, and B. Grabensee Anticoagulation with r-hirudin in a patient with acute renal failure and heparin-induced thrombocytopenia Nephrol Dial Transplant 14 Suppl 4 1999 45 47
25. S. Whelen, and M.E. Carr Jr. Use of recombinant hirudin in heparin-induced thrombocytopenia and thrombosis (HITT) and renal failure - a case report Angiology 52 2001 711 715
26. M.L. Willey, S. de Denus, and S.A. Spinler Removal of lepirudin, a recombinant hirudin, by hemodialysis, hemofiltration, or plasmapheresis Pharmacotherapy 22 2002 492 499
27. B. Unver, G. Sunder-Plassmann, W.H. Horl, and R. Apsner Long-term citrate anticoagulation for high-flux haemodialysis in a patient with heparin-induced thrombocytopenia type II Acta Med Austriaca 29 2002 146 148